HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard Vile Selected Research

Richard Vile Research Topics

Disease

57Neoplasms (Cancer)
11/2023 - 03/2002
16Melanoma (Melanoma, Malignant)
01/2022 - 03/2002
12Vesicular Stomatitis
11/2023 - 10/2002
6Infections
12/2022 - 10/2012
5Experimental Melanoma
06/2023 - 10/2014
3Prostatic Neoplasms (Prostate Cancer)
03/2021 - 12/2007
3Glioma (Gliomas)
06/2017 - 02/2015
2Liver Neoplasms (Liver Cancer)
01/2023 - 01/2018
2Virus Diseases (Viral Diseases)
01/2021 - 10/2012
2Reoviridae Infections
03/2020 - 06/2011
2Urinary Bladder Neoplasms (Bladder Cancer)
10/2019 - 06/2018
2Non-Muscle Invasive Bladder Neoplasms
10/2019 - 06/2018
2Brain Neoplasms (Brain Tumor)
06/2017 - 04/2016
1Squamous Cell Carcinoma of Head and Neck
03/2020
1Squamous Cell Neoplasms (Squamous Cell Cancer)
03/2020
1Wounds and Injuries (Trauma)
11/2017
1Diffuse Intrinsic Pontine Glioma
06/2017
1Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
06/2017
1Neuroblastoma
04/2016
1Hypoxia (Hypoxemia)
04/2016
1Carcinogenesis
01/2016
1Sickle Cell Anemia (Hemoglobin S Disease)
01/2016
1Colorectal Neoplasms (Colorectal Cancer)
05/2013

Drug/Important Bio-Agent (IBA)

21AntigensIBA
01/2022 - 03/2002
8Neoplasm Antigens (Tumor Antigens)IBA
11/2023 - 03/2002
7Proteins (Proteins, Gene)FDA Link
06/2018 - 11/2010
6Neutralizing AntibodiesIBA
12/2022 - 01/2008
5CytokinesIBA
11/2017 - 05/2008
5VaccinesIBA
09/2008 - 10/2002
4Immune Checkpoint InhibitorsIBA
11/2023 - 03/2021
4Antiviral Agents (Antivirals)IBA
01/2021 - 11/2011
4Complementary DNA (cDNA)IBA
01/2016 - 11/2011
4Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2015 - 01/2008
3InterferonsIBA
11/2023 - 02/2011
3Cancer VaccinesIBA
12/2020 - 03/2002
3ChemokinesIBA
01/2020 - 02/2011
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2017 - 05/2010
3AntibodiesIBA
05/2013 - 07/2007
3Therapeutic UsesIBA
10/2011 - 06/2003
3Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2006 - 10/2002
3Glycoproteins (Glycoprotein)IBA
02/2006 - 10/2002
2LigandsIBA
06/2023 - 03/2021
2Interferon Type IIBA
03/2021 - 01/2020
2Chimeric Antigen ReceptorsIBA
01/2020 - 06/2003
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2019 - 06/2018
2Mitomycin (Mitomycin-C)FDA LinkGeneric
10/2019 - 06/2018
2PLX 4720IBA
05/2015 - 05/2015
2Conditioned Culture MediaIBA
02/2015 - 02/2011
2EpitopesIBA
11/2014 - 02/2006
2InterleukinsIBA
03/2012 - 09/2008
2Docetaxel (Taxotere)FDA Link
06/2011 - 11/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2008 - 07/2007
1atezolizumabIBA
11/2023
1Bevacizumab (Avastin)FDA Link
11/2023
1Permethrin (Ambush)FDA LinkGeneric
06/2023
1Peptides (Polypeptides)IBA
06/2023
1Adenosine (Adenocard)FDA LinkGeneric
03/2021
1Programmed Cell Death 1 ReceptorIBA
03/2021
1Member 14 Tumor Necrosis Factor ReceptorsIBA
03/2021
1Viral RNAIBA
01/2021
17- methyl- 5- (1- ((3- (trifluoromethyl)phenyl)acetyl)- 2,3- dihydro- 1H- indol- 5- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 4- amineIBA
03/2020
1Phosphotransferases (Kinase)IBA
03/2020
1Protein Kinases (Protein Kinase)IBA
03/2020
1epidermal growth factor receptor VIIIIBA
01/2020
1CalreticulinIBA
06/2018
1Interleukin-6 (Interleukin 6)IBA
11/2017
1dipinacoline glutamateIBA
06/2017
1Glycogen Synthase (Synthase I)IBA
06/2017
1Cytochromes c (Cytochrome c)IBA
04/2016
1Monophenol Monooxygenase (Tyrosinase)IBA
04/2016
1Sickle HemoglobinIBA
01/2016
1Heme (Haem)IBA
01/2016
1Oxidants (Oxidizing Agents)IBA
01/2016
1hemoglobin AAIBA
01/2016
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2015
1Immunomodulating AgentsIBA
05/2015
1EnzymesIBA
02/2015
1Ganciclovir (Cytovene)FDA LinkGeneric
02/2015
1ProdrugsIBA
02/2015
1Thymidine KinaseIBA
02/2015
1Monoclonal AntibodiesIBA
12/2014
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
10/2014
1Doxorubicin (Adriamycin)FDA LinkGeneric
08/2013
1trioctyl phosphine oxide (TOPO)IBA
08/2013
1Caspase 3 (Caspase-3)IBA
10/2012
1TubulinIBA
10/2012
1Interleukin-17 (Interleukin 17)IBA
03/2012
1Paclitaxel (Taxol)FDA LinkGeneric
10/2011
1Small Interfering RNA (siRNA)IBA
02/2011

Therapy/Procedure

29Therapeutics
11/2023 - 10/2002
18Immunotherapy
11/2023 - 06/2002
11Oncolytic Virotherapy
11/2023 - 12/2002
7Drug Therapy (Chemotherapy)
01/2021 - 11/2010
1Intravesical Administration
10/2019
1Biological Therapy
06/2018
1Intravenous Administration
11/2015
1Radiotherapy
11/2015
1Aftercare (After-Treatment)
05/2015
1Free Tissue Flaps
02/2015
1Intravenous Injections
03/2012